References
- Rex DK, Cummings OW, Shaw M et al. Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology125, 1670–1677 (2003).
- Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology123, 636–639 (2002).
- Kendall BJ, Whiteman DC. Temporal changes in the endoscopic frequency of new cases of Barrett’s esophagus in an Australian health region. Am. J. Gastroenterol.101, 1178–1182 (2006).
- Shaheen NJ, Crosby MA, Bozymski EM et al. Is there publication bias in the reporting of cancer risk in Barrett’s esophagus? Gastroenterology119, 333–338 (2000).
- Buttar NS, Wang KK, Sebo TJ et al. Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology120, 1630–1639 (2001).
- Overholt BF, Lightdale CJ, Wang KK et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized Phase III trial. Gastrointest. Endosc.62, 488–498 (2005).
- Reid BJ, Levine DS, Longton G et al. Predictors of progression to cancer in Barrett’s esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am. J. Gastroenterol.95, 1669–1676 (2000).
- Schnell TG, Sontag SJ, Chejfec G et al. Long-term nonsurgical management of Barrett’s esophagus with high-grade dysplasia. Gastroenterology120, 1607–1619 (2001).
- Rastogi A, Puli S, El-Serag HB et al. Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis. Gastrointest. Endosc.67, 394–398 (2008).
- Wolfsen HC, Utley DS, Peters JH. In: Shackelford’s Surgery of the Alimentary Tract. 6th Edition. Yeo CJ, Dempsey DT, Klein AS, Pemberton JH, Peters JH (Eds). Saunders Elsevier, PA, USA 365–373, (2007).
- Ganz RA, Utley DS, Stern RA et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest. Endosc.60, 1002–1010 (2004).
- Dunkin BJ, Martinez J, Bejarano PA et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg. Endosc.20, 125–130 (2006).
- Smith CD, Bejarano PA, Melvin WS et al. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg. Endosc.21, 560–569 (2007).
- Sharma VK, Wang KK, Overholt BF et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett’s esophagus: 1-year follow-up of 100 patients. Gastrointest. Endosc.65, 185–195 (2007).
- Fleischer DE, Overholt BF, Sharma VK et al. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5 year follow-up. Gastrointest. Endosc. DOI:10.1016/j.gie.2008.03.008 (2008) (Epub ahead of print).
- Roorda AK, Marcus SN, Triadafilopoulos G. Early experience with radiofrequency energy ablation therapy for Barrett’s esophagus with and without dysplasia. Dis. Esophagus20, 516–522 (2007).
- Ganz RA, Overholt BF, Sharma VK et al. Circumferential ablation of Barrett’s esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest. Endosc.68(1), 35–40 (2008).
- Sharma VK, Kim HJ, Das A, Dean P, DePetris G, Fleischer DE. A prospective pilot trial of ablation of Barrett’s esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy.40(5), 380–387 (2008).
- Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Stepwise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy40(5), 359–369 (2008).
- Gondrie JJ, Pouw RE, Sondermeijer CM et al. Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy40(5), 370–379 (2008).
- Finkelstein SD, Lyday WD. The molecular pathology of radiofrequency mucosal ablation of Barrett’s esophagus. Gastroenterology134(4), A436 (2008).
- Gondrie JJ, Rygiel AM, Sondermeijer C et al. Balloon-based circumferential ablation followed by focal ablation of Barrett’s esophagus containing high-grade dysplasia effectively removes all genetic alterations. Gastroenterology132(Suppl. 1), A64 (2007).
- Das A, Wells CD, Fleischer DE et al. Combined modality (circumferential and focal) ablative therapy is a cost-effective (CE) management for non-dysplastic Barrett’s esophagus (NDBE). Gastrointest. Endosc.65, AB151 (2007).
- Inadomi JM, Madanick RD, Somsouk M et al. Radiofrequency ablation is more cost-effective than endoscopic surveillance or esophagectomy among patients with Barrett’s esophagus and low-grade dysplasia. Gastroenterology132 (Suppl. 1), A53 (2007).
Websites
- Ries LAG, Melbert D, Krapcho M et al. (Eds). SEER Cancer Statistics Review, 1975–2005, National Cancer Institute. Bethesda, MD. Based on November 2007 SEER data submission, posted to the SEER website (2008) http://seer.cancer.gov/csr/1975_2005
- Nicholas J, Shaheen A. Randomized, multicenter, sham-controlled trial of radiofrequency ablation (RFA) for subjects with Barrett’s esophagus (BE) containing dysplasia: interim results of the AIM dysplasia trial “AGA Institute Clinical Science Plenary Session.” 19 May 2008. Digestive Disease Week www.siattend.com/BuyRecordings.aspx> Accessed July 8 2008